Who owns Innate Pharma Adr?
- Ticker: IPHA
- CUSIP Number: 45781k204
Tip: Access positions for across all investors
Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Innate Pharma stock
Who bought or sold Innate Pharma Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 93k | $162k | 100% | Dec 2025 |
|
| Lion Point Capital | 81k | $142k | 100% | Dec 2025 |
|
| Old Mission Capital | 28k | $50k | 100% | Dec 2025 |
|
| Millennium Management | 20k | $36k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 5.2k | $9.1k | 1007% | Dec 2025 |
|
| UBS Group | 947.00 | $1.7k | -80% | Dec 2025 |
|
| GAMMA Investing | 240.00 | $307.008000 | -78% | Mar 2026 |
|
| Farther Finance Advisors | 10.00 | $14.000000 | 0% | Mar 2026 |
|
| SageView Advisory Group | 1.00 | $2.000000 | 100% | Dec 2025 |
|
| Barclays | 1.00 | $2.000000 | -100% | Dec 2025 |
|
Who sold out of Innate Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Sep 2025 | 20k | $39k |
| Optiver Holding B.V. | Sep 2025 | 101.00 | $197.000500 |
| Principal Securities | Sep 2025 | 45.00 | $86.998500 |